Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 9, 2011 - Issue 1
Submit an article Journal homepage
380
Views
68
CrossRef citations to date
0
Altmetric
Review

Pathogenesis of arenavirus hemorrhagic fevers

Marie-Laurence Moraz Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland;
&
Stefan Kunz Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland; Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland
Pages 49-59 | Published online: 10 Jan 2014

Citations (68)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Harshal Sudhakar, Jignesh Bhate & Asish Kumar Patra. (2020) Patent landscape of novel technologies for combating category-A Arenavirus infections. Expert Opinion on Therapeutic Patents 30:7, pages 557-565.
Read now
Igor S. Lukashevich & Peter Pushko. (2016) Vaccine platforms to control Lassa fever. Expert Review of Vaccines 15:9, pages 1135-1150.
Read now
Antonella Pasquato & Stefan Kunz. (2016) Novel drug discovery approaches for treating arenavirus infections. Expert Opinion on Drug Discovery 11:4, pages 383-393.
Read now
Christina F Spiropoulou & Anon Srikiatkhachorn. (2013) The role of endothelial activation in dengue hemorrhagic fever and hantavirus pulmonary syndrome. Virulence 4:6, pages 525-536.
Read now
Igor S Lukashevich. (2013) The search for animal models for Lassa fever vaccine development. Expert Review of Vaccines 12:1, pages 71-86.
Read now

Articles from other publishers (63)

Lucille Blumberg, Tom Fletcher, Delia Enria & Daniel G. Bausch. 2024. Manson's Tropical Diseases. Manson's Tropical Diseases 212 233 .
Miyuki Kimura, Risa Matsuoka, Satoshi Taniguchi, Junki Maruyama, Slobodan Paessler, Saori Oka, Atsushi Yamashita, Takasuke Fukuhara, Yoshiharu Matsuura & Hideki Tani. (2023) Inhibitors of cannabinoid receptor 1 suppress the cellular entry of Lujo virus. Virology 587, pages 109867.
Crossref
Curtis Cline, Xiankun Zeng, Todd M. Bell, Carl Shaia, Paul Facemire, Janice Williams, Neil Davis, April Babka, Edwin Picado, Colin Fitzpatrick & Joseph W. Golden. (2023) Temporal changes in pathology and viral RNA distribution in guinea pigs following separate infection with two New World Arenaviruses. PLOS Neglected Tropical Diseases 17:9, pages e0011620.
Crossref
H.J.A. Fleury. 2023. Virus émergents et Ré-émergents. Virus émergents et Ré-émergents 59 62 .
Mary Choi, Jonathan Dyal & James Graziano. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases 1213 1219.e2 .
Jonna B. Westover, Shibani Naik, Kevin W. Bailey, Luci Wandersee, Vidyasagar R. Gantla, Brady T. Hickerson, Ken McCormack, Greg Henkel & Brian B. Gowen. (2022) Severe mammarenaviral disease in Guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir. Antiviral Research, pages 105444.
Crossref
Takeshi Saito, Takanari Hattori, Kosuke Okuya, Rashid Manzoor, Hiroko Miyamoto, Masahiro Kajihara & Ayato Takada. (2022) Molecular Mechanisms Underlying the Cellular Entry and Host Range Restriction of Lujo Virus. mBio 13:1.
Crossref
Lingzhi Zhu, Guihua Duan, Cheng Yan & Jianxin Wang. (2021) Identifying virus-receptor interactions through matrix completion with similarity fusion. Identifying virus-receptor interactions through matrix completion with similarity fusion.
Brian B. Gowen, Shibani Naik, Jonna B. Westover, Eric R. Brown, Vidyasagar R. Gantla, Alexandra Fetsko, Ashley L. Dagley, Dallan J. Blotter, Nicole Anderson, Ken McCormack & Greg Henkel. (2021) Potent inhibition of arenavirus infection by a novel fusion inhibitor. Antiviral Research 193, pages 105125.
Crossref
Kul Raj Rai, Prasha Shrestha, Bincai Yang, Yuhai Chen, Shasha Liu, Mohamed Maarouf & Ji-Long Chen. (2021) Acute Infection of Viral Pathogens and Their Innate Immune Escape. Frontiers in Microbiology 12.
Crossref
So Ri Jung, Thomas M. Ashhurst, Phillip K. West, Barney Viengkhou, Nicholas J. C. King, Iain L. Campbell & Markus J. Hofer. (2020) Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection. PLOS Pathogens 16:4, pages e1008525.
Crossref
Hamed Memariani, Mojtaba Memariani, Hamideh Moravvej & Mohammad Shahidi-Dadras. (2019) Melittin: a venom-derived peptide with promising anti-viral properties. European Journal of Clinical Microbiology & Infectious Diseases 39:1, pages 5-17.
Crossref
Cheng Yan, Guihua Duan, Fang-Xiang Wu & Jianxin Wang. (2019) IILLS: predicting virus-receptor interactions based on similarity and semi-supervised learning. BMC Bioinformatics 20:S23.
Crossref
Marco Iannetta, Antonino Di Caro, Emanuele Nicastri, Francesco Vairo, Honorati Masanja, Gary Kobinger, Ali Mirazimi, Francine Ntoumi, Alimuddin Zumla & Giuseppe Ippolito. (2019) Viral Hemorrhagic Fevers Other than Ebola and Lassa. Infectious Disease Clinics of North America 33:4, pages 977-1002.
Crossref
Anastasiya Shulman, Michael Katz, Hadas Cohen-Dvashi, Harry M. Greenblatt, Yaakov Levy & Ron Diskin. (2019) Variations in Core Packing of GP2 from Old World Mammarenaviruses in their Post-Fusion Conformations Affect Membrane-Fusion Efficiencies. Journal of Molecular Biology 431:11, pages 2095-2111.
Crossref
Aliza Borenstein-Katz, Anastasiya Shulman, Hedva Hamawi, Orith Leitner & Ron Diskin. (2019) Differential Antibody-Based Immune Response against Isolated GP1 Receptor-Binding Domains from Lassa and Junín Viruses. Journal of Virology 93:8.
Crossref
Hadas Cohen-Dvashi, Itay Kilimnik & Ron Diskin. (2018) Structural basis for receptor recognition by Lujo virus. Nature Microbiology 3:10, pages 1153-1160.
Crossref
Florencia Linero, Claudia Sepúlveda, Ioanna Christopoulou, Paco Hulpiau, Luis Scolaro & Xavier Saelens. (2018) Neutralization of Junín virus by single domain antibodies targeted against the nucleoprotein. Scientific Reports 8:1.
Crossref
Chiara Fedeli, Héctor Moreno & Stefan Kunz. (2018) Novel Insights into Cell Entry of Emerging Human Pathogenic Arenaviruses. Journal of Molecular Biology 430:13, pages 1839-1852.
Crossref
Matthijs Raaben, Lucas T. Jae, Andrew S. Herbert, Ana I. Kuehne, Sarah H. Stubbs, Yi-ying Chou, Vincent A. Blomen, Tomas Kirchhausen, John M. Dye, Thijn R. Brummelkamp & Sean P. Whelan. (2017) NRP2 and CD63 Are Host Factors for Lujo Virus Cell Entry. Cell Host & Microbe 22:5, pages 688-696.e5.
Crossref
Nicolás SaruteSusan R. Ross. (2017) New World Arenavirus Biology. Annual Review of Virology 4:1, pages 141-158.
Crossref
Hinh Ly. (2017) Differential Immune Responses to New World and Old World Mammalian Arenaviruses. International Journal of Molecular Sciences 18:5, pages 1040.
Crossref
Yusuf Abba, Hasliza Hassim, Hazilawati Hamzah, Omar Emad Ibrahim, Mohd Azmi Mohd Lila & Mohamed Mustapha Noordin. (2017) Pathological vicissitudes and oxidative stress enzyme responses in mice experimentally infected with reptarenavirus (isolate UPM/MY01). Microbial Pathogenesis 104, pages 17-27.
Crossref
Yousuke FURUTATakashi KOMENO & Takaaki NAKAMURA. (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proceedings of the Japan Academy, Series B 93:7, pages 449-463.
Crossref
Guo-Yun Yu, Suzanne Mate, Karla Garcia, Michael D. Ward, Ernst Brueggemann, Matthew Hall, Tara Kenny, Mariano Sanchez-Lockhart, Marie-Paule Lefranc & Gustavo Palacios. (2016) Cynomolgus macaque (Macaca fascicularis) immunoglobulin heavy chain locus description. Immunogenetics 68:6-7, pages 417-428.
Crossref
Vivian Vasconcelos Costa, Danielle da Gloria de Souza & Mauro Martins Teixeira. 2016. Vascular Responses to Pathogens. Vascular Responses to Pathogens 161 181 .
Igor S. Lukashevich. 2015. Human Emerging and Re‐emerging Infections. Human Emerging and Re‐emerging Infections 1 27 .
Brian B. Gowen, Eric J. Sefing, Jonna B. Westover, Donald F. Smee, Joseph Hagloch, Yousuke Furuta & Jeffery O. Hall. (2015) Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever. Antiviral Research 121, pages 132-137.
Crossref
J. Hepojoki, P. Salmenperä, T. Sironen, U. Hetzel, Y. Korzyukov, A. Kipar & O. Vapalahti. (2015) Arenavirus Coinfections Are Common in Snakes with Boid Inclusion Body Disease. Journal of Virology 89:16, pages 8657-8660.
Crossref
Junjie Shao, Yuying Liang & Hinh Ly. (2015) Human Hemorrhagic Fever Causing Arenaviruses: Molecular Mechanisms Contributing to Virus Virulence and Disease Pathogenesis. Pathogens 4:2, pages 283-306.
Crossref
Juliane I. Beier, Jenny D. Jokinen, Gretchen E. Holz, Patrick S. Whang, Amah M. Martin, Nikole L. Warner, Gavin E. Arteel & Igor S. Lukashevich. (2015) Novel Mechanism of Arenavirus-Induced Liver Pathology. PLOS ONE 10:3, pages e0122839.
Crossref
Juan C Zapata & Maria S Salvato. (2015) Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man. Future Virology 10:3, pages 233-256.
Crossref
R. Kerber, S. Reindl, V. Romanowski, R.M. Gómez, E. Ogbaini-Emovon, S. Günther & J. ter Meulen. (2015) Research efforts to control highly pathogenic arenaviruses: A summary of the progress and gaps. Journal of Clinical Virology 64, pages 120-127.
Crossref
Jussi Hepojoki, Anja Kipar, Yegor Korzyukov, Lesley Bell-Sakyi, Olli Vapalahti & Udo Hetzel. (2015) Replication of Boid Inclusion Body Disease-Associated Arenaviruses Is Temperature Sensitive in both Boid and Mammalian Cells. Journal of Virology 89:2, pages 1119-1128.
Crossref
Erich R. Mackow, Elena E. Gorbunova & Irina N. Gavrilovskaya. (2015) Endothelial cell dysfunction in viral hemorrhage and edema. Frontiers in Microbiology 5.
Crossref
Joseph W. Golden, Christopher D. Hammerbeck, Eric M. Mucker & Rebecca L. Brocato. (2015) Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses. BioMed Research International 2015, pages 1-31.
Crossref
Darci R. Smith, Michael R. Holbrook & Brian B. Gowen. (2014) Animal models of viral hemorrhagic fever. Antiviral Research 112, pages 59-79.
Crossref
Jung-Chen Lin, Shih-Ching Lin, Wen-Yu Chen, Yu-Ting Yen, Chin-Wen Lai, Mi-Hua Tao, Yi-Ling Lin, Shi-Chuen Miaw & Betty A. Wu-Hsieh. (2014) Dengue Viral Protease Interaction with NF-κB Inhibitor α/β Results in Endothelial Cell Apoptosis and Hemorrhage Development. The Journal of Immunology 193:3, pages 1258-1267.
Crossref
Lisa McLay, Yuying Liang & Hinh Ly. (2014) Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections. Journal of General Virology 95:1, pages 1-15.
Crossref
Lucille Blumberg, Delia Enria & Daniel G. Bausch. 2014. Manson's Tropical Infectious Diseases. Manson's Tropical Infectious Diseases 171 194.e2 .
Judith F. Aronson. 2014. Viruses and the Lung. Viruses and the Lung 123 132 .
Brian B. Gowen, Terry L. Juelich, Eric J. Sefing, Trevor Brasel, Jennifer K. Smith, Lihong Zhang, Bersabeh Tigabu, Terence E. Hill, Tatyana Yun, Colette Pietzsch, Yousuke Furuta & Alexander N. Freiberg. (2013) Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever. PLoS Neglected Tropical Diseases 7:12, pages e2614.
Crossref
Eric J Sefing, Min-Hui Wong, Deanna P Larson, Brett L Hurst, Arnaud J Van Wettere, Stewart W Schneller & Brian B Gowen. (2013) Vascular leak ensues a vigorous proinflammatory cytokine response to Tacaribe arenavirus infection in AG129 mice. Virology Journal 10:1.
Crossref
Yousuke Furuta, Brian B. Gowen, Kazumi Takahashi, Kimiyasu Shiraki, Donald F. Smee & Dale L. Barnard. (2013) Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Research 100:2, pages 446-454.
Crossref
Udo Hetzel, Tarja Sironen, Pasi Laurinmäki, Lassi Liljeroos, Aino Patjas, Heikki Henttonen, Antti Vaheri, Annette Artelt, Anja Kipar, Sarah J. Butcher, Olli Vapalahti & Jussi Hepojoki. (2013) Isolation, Identification, and Characterization of Novel Arenaviruses, the Etiological Agents of Boid Inclusion Body Disease. Journal of Virology 87:20, pages 10918-10935.
Crossref
Juan Carlos Zapata, Ricardo Carrion, Jean L. Patterson, Oswald Crasta, Yan Zhang, Sachin Mani, Marti Jett, Bhawna Poonia, Mahmoud Djavani, David M. White, Igor S. Lukashevich & Maria S. Salvato. (2013) Transcriptome Analysis of Human Peripheral Blood Mononuclear Cells Exposed to Lassa Virus and to the Attenuated Mopeia/Lassa Reassortant 29 (ML29), a Vaccine Candidate. PLoS Neglected Tropical Diseases 7:9, pages e2406.
Crossref
Louis Huzella, Jennifer Cann, Matthew Lackemeyer, Victoria Wahl-Jensen, Peter Jahrling, Jens Kuhn & Donna Perry. 2013. Viral Hemorrhagic Fevers. Viral Hemorrhagic Fevers 15 30 .
R. Bodewes, M. J. L. Kik, V. Stalin Raj, C. M. E. Schapendonk, B. L. Haagmans, S. L. Smits & A. D. M. E. Osterhaus. (2013) Detection of novel divergent arenaviruses in boid snakes with inclusion body disease in The Netherlands. Journal of General Virology 94:6, pages 1206-1210.
Crossref
Xue Jiang, Qinfeng Huang, Wenjian Wang, Haohao Dong, Hinh Ly, Yuying Liang & Changjiang Dong. (2013) Structures of Arenaviral Nucleoproteins with Triphosphate dsRNA Reveal a Unique Mechanism of Immune Suppression. Journal of Biological Chemistry 288:23, pages 16949-16959.
Crossref
Ricardo M. GómezMirta Schattner. (2013) Arenaviruses bite the “dust”. Blood 121:6, pages 868-869.
Crossref
Gilbert David Loria, Pablo A. RomagnoliNelson B. MoseleyAlexandra Rucavado & John D. Altman. (2013) Platelets support a protective immune response to LCMV by preventing splenic necrosis. Blood 121:6, pages 940-950.
Crossref
Lisa McLay, Aftab Ansari, Yuying Liang & Hinh Ly. (2013) Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever. Antiviral Research 97:2, pages 81-92.
Crossref
Mirta Schattner, Leonardo Rivadeneyra, Roberto Pozner & Ricardo Gómez. (2013) Pathogenic Mechanisms Involved in the Hematological Alterations of Arenavirus-induced Hemorrhagic Fevers. Viruses 5:1, pages 340-351.
Crossref
Magali Droniou-Bonzom & Paula Cannon. (2012) A Systems Biology Starter Kit for Arenaviruses. Viruses 4:12, pages 3625-3646.
Crossref
Igor Lukashevich. (2012) Advanced Vaccine Candidates for Lassa Fever. Viruses 4:11, pages 2514-2557.
Crossref
Melissa Hayes & Maria Salvato. (2012) Arenavirus Evasion of Host Anti-Viral Responses. Viruses 4:10, pages 2182-2196.
Crossref
Brian H. Bird, Kimberly A. Dodd, Bobbie R. Erickson, César G. Albariño, Ayan K. Chakrabarti, Laura K. McMullan, Eric Bergeron, Ute Ströeher, Deborah Cannon, Brock Martin, JoAnn D. Coleman-McCray, Stuart T. Nichol & Christina F. Spiropoulou. (2012) Severe Hemorrhagic Fever in Strain 13/N Guinea Pigs Infected with Lujo Virus. PLOS Neglected Tropical Diseases 6:8, pages e1801.
Crossref
Melissa W. Hayes, Ricardo CarrionJr.Jr., Jerritt Nunneley, Andrei E. Medvedev, Maria S. Salvato & Igor S. Lukashevich. (2012) Pathogenic Old World Arenaviruses Inhibit TLR2/Mal-Dependent Proinflammatory Cytokines In Vitro . Journal of Virology 86:13, pages 7216-7226.
Crossref
Jillian M. Rojek, Marie-Laurence Moraz, Christelle Pythoud, Sylvia Rothenberger, F. Gisou Van der Goot, Kevin P. Campbell & Stefan Kunz. (2012) Binding of Lassa virus perturbs extracellular matrix-induced signal transduction via dystroglycan. Cellular Microbiology 14:7, pages 1122-1134.
Crossref
Marco A. Goicochea, Juan C. Zapata, Joseph Bryant, Harry Davis, Maria S. Salvato & Igor S. Lukashevich. (2012) Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model. Vaccine 30:8, pages 1445-1452.
Crossref
Daniel G. Bausch. 2012. Goldman's Cecil Medicine. Goldman's Cecil Medicine 2147 2156 .
D. Safronetz, H. Feldmann & D. Falzarano. 2012. Medical Microbiology. Medical Microbiology 546 558 .
Brian B GowenMike Bray. (2011) Progress in the experimental therapy of severe arenaviral infections. Future Microbiology 6:12, pages 1429-1441.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.